Foley & Lardner LLP partner Natasha Allen offered insight on California legislation aimed at artificial intelligence in The Recorder article, “Innovation vs. Regulation Debate Reaches Gov. Gavin Newsom as AI Bills Hit His Desk.”
Allen commented on one key issue for some AI developers in California SB 1047, which would assign liability for products that could be refined and redeveloped many times in ways the original creator could not have envisioned.
“A lot of these models develop and learn on iterations of the model,” Allen explained. “It’s just difficult for them to even make this assessment on day one, to say this model at some point in the future will not be something completely different.”
(Subscription required)
People
Related News
06 September 2024
In the News
Old Employment Law Principles Can Answer New AI Concerns
The integration of artificial intelligence into the workplace has sparked a flurry of legal and regulatory discussions in recent months.
04 September 2024
In the News
Nathaniel Lacktman Comments on Prospect of Regressive DEA Stance on Telemedicine Prescribing of Controlled Substances
Foley & Lardner LLP partner Nathaniel Lacktman, chair of firm’s national Telemedicine & Digital Health Industry Team and member of the American Telemedicine Association Board of Directors, offered insight on how providers might prepare if the U.S. Drug Enforcement Agency (DEA) issues regressive regulations on telemedicine prescribing in the Modern Healthcare article, “Specter of strict DEA prescribing rule rattles telehealth sector.”
04 September 2024
In the News
Louis Lehot on Biotech IPOs – 'Biotech could have a great fourth quarter'
Foley & Lardner LLP partner Louis Lehot offered insight on the biotech industry’s upcoming initial public offerings in the Bloomberg Law article, “Biotech IPO Hopefuls Ready Burst of Debuts After Rough Stretch.”